Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56008-20-9

Post Buying Request

56008-20-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56008-20-9 Usage

Description

3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one is a chemical compound with the molecular formula C14H17NO. It is a member of the indole class of organic compounds, which are characterized by a bicyclic aromatic ring system that includes a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. 3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one's name suggests the presence of three methyl groups and a cyclic ketone functional group on the base indole structure. However, specific information about its properties, uses, or biological activity is not widely available, suggesting that it may not have been extensively studied or commercially utilized.

Uses

Due to the limited information available on 3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one, it is challenging to provide a comprehensive list of its applications. However, based on its classification as an indole compound, we can infer potential uses in various industries, which may include:
Used in Pharmaceutical Industry:
3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one could be used as a chemical intermediate or a building block for the synthesis of more complex molecules with potential pharmaceutical applications. Its structure may allow for the development of new drugs or the modification of existing ones to improve their efficacy or reduce side effects.
Used in Chemical Research:
In the field of chemical research, 3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one may serve as a subject of study for understanding the properties and reactivity of indole compounds. Researchers may explore its potential as a catalyst, ligand, or precursor in various chemical reactions.
Used in Material Science:
3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one's unique structure may also make it a candidate for the development of new materials with specific properties, such as conductivity, magnetism, or optical activity. It could be used as a component in the synthesis of advanced materials for applications in electronics, energy storage, or sensing technologies.

Check Digit Verification of cas no

The CAS Registry Mumber 56008-20-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,0,0 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 56008-20:
(7*5)+(6*6)+(5*0)+(4*0)+(3*8)+(2*2)+(1*0)=99
99 % 10 = 9
So 56008-20-9 is a valid CAS Registry Number.

56008-20-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,6,6-trimethyl-5,7-dihydro-1H-indol-4-one

1.2 Other means of identification

Product number -
Other names 3,6,6-Trimethyl-1,5,6,7-tetrahydro-indol-4-on

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56008-20-9 SDS

56008-20-9Relevant articles and documents

-

Falk et al.

, p. 1019,1020 (1974)

-

HYDROXAMATE DERIVATIVES FOR HDAC INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THEREOF

-

Paragraph 0417-0419; 0463-0465, (2014/10/29)

The present invention relates to a novel hydroxamate derivatives, more specifically, to novel hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC), isomers thereof, pharmaceutically acceptable salts thereof, hydrates or solvates thereof, use for preparing pharmaceutical compositions, pharmaceutical compositions comprising the same, treatment method using said composition, and a preparing method of novel hydroxamate derivatives. The novel selective hydroxamate derivatives having inhibitory activity against Histone Deacetylase (HDAC) compositions can be used for treatment of inflammatory disease, rheumatoid arthritis, or degenerative disease.

Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents

Huang, Kenneth H.,Veal, James M.,Fadden, R. Patrick,Rice, John W.,Eaves, Jeron,Strachan, Jon-Paul,Barabasz, Amy F.,Foley, Briana E.,Barta, Thomas E.,Ma, Wei,Silinski, Melanie A.,Hu, Mei,Partridge, Jeffrey M.,Scott, Anisa,DuBois, Laura G.,Freed, Tiffany,Steed, Paul M.,Ommen, Andy J.,Smith, Emilie D.,Hughes, Philip F.,Woodward, Angela R.,Hanson, Gunnar J.,McCall, W. Stephen,Markworth, Christopher J.,Hinkley, Lindsay,Jenks, Matthew,Geng, Lifeng,Lewis, Meredith,Otto, James,Pronk, Bert,Verleysen, Katleen,Hall, Steven E.

experimental part, p. 4288 - 4305 (2010/01/16)

A novel class of heat shock protein 90 (Hsp90) inhibitors was developed from an unbiased screen to identify protein targets for a diverse compound library. These indol-4-one and indazol-4-one derived 2-aminobenzamides showed strong binding affinity to Hsp

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56008-20-9